Goosehead Insurance Inc expected to post earnings of 48 cents a share - Earnings Preview
Goosehead Insurance Inc expected to post earnings of 48 cents a share - Earnings Preview
Goosehead Insurance Inc GSHD.OQ GSHD.O is expected to show a rise in quarterly revenue when it reports results on July 22 for the period ending June 30 2026
The Westlake Texas-based company is expected to report a 9.9% increase in revenue to $103.356 million from $94.03 million a year ago, according to the mean estimate from 9 analysts, based on LSEG data.
LSEG's mean analyst estimate for Goosehead Insurance Inc is for earnings of 48 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 6 "strong buy" or "buy," 6 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Goosehead Insurance Inc is $72.00, about 32.6% above its last closing price of $54.28
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | 0.21 | 0.20 | 0.37 | Beat | 83 |
Dec. 31 2026 | 0.61 | 0.58 | 0.64 | Beat | 11.3 |
Sep. 30 2025 | 0.47 | 0.46 | 0.46 | Met | 0.4 |
Jun. 30 2025 | 0.49 | 0.50 | 0.49 | Missed | -2.1 |
Mar. 31 2025 | 0.22 | 0.22 | 0.26 | Beat | 19.4 |
Dec. 31 2024 | 0.40 | 0.40 | 0.79 | Beat | 99 |
Sep. 30 2024 | 0.45 | 0.45 | 0.50 | Beat | 10.5 |
Jun. 30 2024 | 0.39 | 0.39 | 0.43 | Beat | 10 |
This summary was machine generated July 20 at 20:28 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Goosehead Insurance
See all newsGoosehead Insurance, Inc. expected to post earnings of 51 cents a share - Earnings Preview
US RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Live Markets: Wall Street turns red as benchmark Treasury yield touches 19-year high